Herrlich Research Group

Publications

2019

  • CD44 deletion suppresses atypia in the precancerous mouse testis.
    Li* H, Shukla* S, Frappart L, Herrlich** P, Ploubidou** A
    Mol Carcinog 2019, 58(5), 621-6 * equal contribution, ** co-corresponding authors

2018

  • Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.
    Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, Shalapour S, Yang L, Valasek MA, Lee S, Minnich K, Seki E, Tuckermann J, Sibilia M, Zucman-Rossi J, Karin M
    Cancer Cell 2018, 33(6), 1061-1077.e6
  • Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44-/- tumor cells, MEFs and macrophages.
    Schultz* K, Grieger (Lindner)* C, Li Y, Urbánek P, Ruschel A, Minnich K, Bruder D, Gereke M, Sechi A, Herrlich P
    PLoS One 2018, 13(12), e0207358 * equal contribution

2017

  • ADAM Metalloprotease-Released Cancer Biomarkers.
    Herrlich P, Herrlich A
    Trends Cancer 2017, 3(7), 482-90
  • Spindle Misorientation of Cerebral and Cerebellar Progenitors Is a Mechanistic Cause of Megalencephaly.
    Li H, Kroll T, Moll J, Frappart L, Herrlich P, Heuer H, Ploubidou A
    Stem Cell Reports 2017, 9(4), 1071-80

Best Paper

The JBC paper on Ectodomain Cleavage has been selected as one of the best JBC papers of the year.